MA27607A1 - Peptides cyto-modulateurs pour traiter la cystite interstitielle - Google Patents
Peptides cyto-modulateurs pour traiter la cystite interstitielleInfo
- Publication number
- MA27607A1 MA27607A1 MA28336A MA28336A MA27607A1 MA 27607 A1 MA27607 A1 MA 27607A1 MA 28336 A MA28336 A MA 28336A MA 28336 A MA28336 A MA 28336A MA 27607 A1 MA27607 A1 MA 27607A1
- Authority
- MA
- Morocco
- Prior art keywords
- interstitial cystitis
- cyto
- treatment
- methods
- modulating peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Les méthodes et compositions concernent le traitement de troubles de la vessie, en particulier, les méthodes fournissent un traitement contre la cystite interstitielle et les troubles y relatifs. Les méthodes comprennent en outre le traitement pour affecter plusieurs manifestations associées à la cystite interstitielle, y compris, la réduction de la libération d'histamine, la modulation de l'expression de la Substance P, la modulation de l'expression du facteur de croissance des neurones, la modulation des niveaux de plusieurs cytokines, et le maintien de l'intégrité de la barrière urine/sang.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42668402P | 2002-11-15 | 2002-11-15 | |
US47083903P | 2003-05-15 | 2003-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27607A1 true MA27607A1 (fr) | 2005-11-01 |
Family
ID=32329122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28336A MA27607A1 (fr) | 2002-11-15 | 2005-06-14 | Peptides cyto-modulateurs pour traiter la cystite interstitielle |
Country Status (13)
Country | Link |
---|---|
US (1) | US7671026B2 (fr) |
EP (1) | EP1594519A4 (fr) |
JP (1) | JP2006516546A (fr) |
KR (1) | KR20050086676A (fr) |
AU (1) | AU2003294357A1 (fr) |
BR (1) | BR0316290A (fr) |
CA (1) | CA2505922A1 (fr) |
CO (1) | CO5640064A2 (fr) |
MA (1) | MA27607A1 (fr) |
MX (1) | MXPA05005101A (fr) |
NO (1) | NO20052814L (fr) |
RU (1) | RU2005118425A (fr) |
WO (1) | WO2004045554A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2069791B1 (fr) * | 2006-07-27 | 2012-01-25 | University of Maryland, Baltimore | Recepteur cellulaire du facteur antiproliferation |
DK2252627T3 (en) * | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
AU2009282625A1 (en) * | 2008-08-18 | 2010-02-25 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Derivatives of APF and methods of use |
JP5857056B2 (ja) | 2010-10-14 | 2016-02-10 | ザイジェン インフラメーション エルティーディー | 慢性又は非慢性の炎症性眼疾患を治療するためのjnkシグナル伝達経路の細胞透過性ペプチド阻害剤の使用 |
WO2014204988A2 (fr) | 2013-06-17 | 2014-12-24 | Asana Biosciences, Llc | Molécule d'immunofusion ciblant 5t4 et procédés correspondants |
WO2015197194A2 (fr) * | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | Nouvelle utilisation d'inhibiteurs peptidiques perméables aux cellules de la voie de transduction du signal jnk pour le traitement de diverses maladies |
WO2014206426A1 (fr) * | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | Nouvelle utilisation des molécules inhibitrices de la jnk pour le traitement de diverses maladies |
WO2014206427A1 (fr) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | Nouvelle utilisation d'inhibiteurs de peptides à perméabilité cellulaire dans la voie de transduction du signal jnk pour le traitement de diverses maladies |
WO2015197097A1 (fr) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | Nouvelle utilisation pour des molécules inhibitrices de la jnk, pour le traitement de diverses maladies |
US10859579B2 (en) * | 2016-03-31 | 2020-12-08 | William Beaumont Hospital | Methods for detecting, diagnosing and treating ulcerative interstitial cystitis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
CN1216900C (zh) * | 1997-04-11 | 2005-08-31 | 桑斯塔特医学有限公司 | 用于调节免疫系统活性和抑制炎症的细胞调节性亲脂肽 |
JP2002512259A (ja) * | 1998-04-17 | 2002-04-23 | ユニバーシティ・オブ・メリーランド, ボルティモア | 組換えヘパリン結合性上皮成長因子様成長因子(hb−egf)による間質性膀胱炎の治療方法 |
PL374700A1 (en) * | 2002-09-20 | 2005-10-31 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
-
2003
- 2003-11-17 RU RU2005118425/14A patent/RU2005118425A/ru not_active Application Discontinuation
- 2003-11-17 MX MXPA05005101A patent/MXPA05005101A/es not_active Application Discontinuation
- 2003-11-17 EP EP03789840A patent/EP1594519A4/fr not_active Ceased
- 2003-11-17 JP JP2004570638A patent/JP2006516546A/ja active Pending
- 2003-11-17 CA CA002505922A patent/CA2505922A1/fr not_active Abandoned
- 2003-11-17 WO PCT/US2003/037043 patent/WO2004045554A2/fr active Application Filing
- 2003-11-17 BR BR0316290-7A patent/BR0316290A/pt not_active Application Discontinuation
- 2003-11-17 US US10/535,167 patent/US7671026B2/en not_active Expired - Fee Related
- 2003-11-17 KR KR1020057008774A patent/KR20050086676A/ko not_active Application Discontinuation
- 2003-11-17 AU AU2003294357A patent/AU2003294357A1/en not_active Abandoned
-
2005
- 2005-06-10 NO NO20052814A patent/NO20052814L/no unknown
- 2005-06-14 MA MA28336A patent/MA27607A1/fr unknown
- 2005-06-14 CO CO05057644A patent/CO5640064A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006516546A (ja) | 2006-07-06 |
AU2003294357A1 (en) | 2004-06-15 |
EP1594519A2 (fr) | 2005-11-16 |
CO5640064A2 (es) | 2006-05-31 |
EP1594519A4 (fr) | 2006-08-16 |
KR20050086676A (ko) | 2005-08-30 |
MXPA05005101A (es) | 2005-09-08 |
WO2004045554A2 (fr) | 2004-06-03 |
BR0316290A (pt) | 2005-10-11 |
NO20052814D0 (no) | 2005-06-10 |
RU2005118425A (ru) | 2006-02-10 |
NO20052814L (no) | 2005-08-04 |
US7671026B2 (en) | 2010-03-02 |
CA2505922A1 (fr) | 2004-06-03 |
US20060194738A1 (en) | 2006-08-31 |
WO2004045554A3 (fr) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27607A1 (fr) | Peptides cyto-modulateurs pour traiter la cystite interstitielle | |
MA27929A1 (fr) | Utilisation de calcitonine pour le traitement de l'osteoarthrite | |
WO2005034843A3 (fr) | Methodes d'utilisation de cellules regeneratrices dans le traitement d'une maladie vasculaire peripherique et dans d'autres troubles associes | |
BR0015110A (pt) | Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos | |
MY151032A (en) | Treatment of tnf? related disorders | |
WO2005096990A3 (fr) | Nouvelle modification de protheses medicales | |
DK1429780T3 (da) | Fremgangsmåde til behandling af mellemoreinfektioner | |
WO2004066990A3 (fr) | Methodes destinees a traiter les troubles du tractus urinaire inferieur au moyen de modulateurs du canal sodique | |
EP2465923A3 (fr) | Procédé pour l'utilisation de cellules dérivées de tissu adipeux pour le traitement de troubles cardio-vasculaires | |
WO2000051587A3 (fr) | Inhibiteurs de jak-3 destines au traitement de troubles allergiques | |
MX2008006076A (es) | Metodos, composiciones y kits para el tratamiento de condiciones medicas. | |
DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
WO2002015920A3 (fr) | Traitement des maladies d'hyperproliferation | |
NO20015969D0 (no) | Forbedret sklerittprotese for behandling av presbyopi og andre öyesykdommer | |
ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
WO2005060960A3 (fr) | Utilisation de l'histamine pour le traitement de maladies osseuses | |
ATE448779T1 (de) | Methode zur behandlung trockener augen und uveitis | |
WO2006012521A3 (fr) | Traitement de maladies oculaires | |
WO2006022612A3 (fr) | Methodes d'utilisation de cellules regeneratrices dans le traitement d'accident vasculaire cerebral et de maladies et de troubles lies | |
ATE349218T1 (de) | Methode zur behandlung von schizophrenie | |
PT1000046E (pt) | Derivados de piperazina activos no trato urinario inferior | |
WO2003092701A3 (fr) | Utilisation d'acides amino-alcane-phosphoniques substitués | |
DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
WO2002036124A3 (fr) | Procede de traitement | |
ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs |